MedPath

Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates

Completed
Conditions
Pelvic Organ Prolapse
Registration Number
NCT00581412
Lead Sponsor
University of California, Irvine
Brief Summary

This study is to determine whether the use of a composite biologic/synthetic graft during abdominal sacrocolpopexy leads to a lower rate of erosion while maintaining durability.

Detailed Description

This study will examine the erosion rate of a composite graft that is being used during abdominal sacrocolpopexy. The composite graft is composed of a dual layer of biological and syntheric material. Biological grafts have the advantage of significantly reducing erosion rates, but the longevity of biologic graft is uncertain. On the other hand, synthetic grafts have the advantage in that they are durable, but have higher erosion rates through the vagina and require re-operation in a small percentage of patients. This study will look at whether or not the use of a composite greaft carries the advantages of both types of materials and leads to decreased rates of erosion while maintaining longevity. The cost effectiveness of this new type of graft will also be reviewed since the disavantage of utilizing both the synthetic and biologic graft is that it will increase the cost.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Patients who underwent abdominal sacrocolpopexy with Drs. Noblett and Lane from 2001 to present
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The erosion rates of composite biologic/syntheric grafts and synthetic-only grafts will be compared.To the point of graft erosion after abdominal sacrocolpopexy
Secondary Outcome Measures
NameTimeMethod
Cost effectiveness will be examined by comparing the price of a composite graft to the cost of re-operation due to erosion of a synthetic-only graft.To the point of graft erosion after abdominal sacrocolpopexy

Trial Locations

Locations (1)

University of California, Irvine Medical Center

🇺🇸

Orange, California, United States

© Copyright 2025. All Rights Reserved by MedPath